openPR Logo
Press release

Immunoglobulin Market Set to Surge to USD 24.9 Billion by 2032 at a 5.1% CAGR

10-15-2024 08:54 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: IMARC Group

Immunoglobulin Market

Immunoglobulin Market

๐†๐ฅ๐จ๐›๐š๐ฅ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ: ๐Š๐ž๐ฒ ๐’๐ญ๐š๐ญ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ ๐š๐ง๐ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ

๐’๐ฎ๐ฆ๐ฆ๐š๐ซ๐ฒ:

โ— The global immunoglobulin market size reached USD 15.7 Billion in 2023.
โ— The market is expected to reach USD 24.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.
โ— North America leads the market, accounting for the largest immunoglobulin market share.
โ— IgG accounts for the majority of the market share in the product segment due to IgG's effectiveness and safety profile.
โ— Immunodeficiency disease holds the largest share in the immunoglobulin industry.
โ— Intravenous mode of delivery remains a dominant segment in the market owing to the established protocols and healthcare infrastructure for intravenous administration.
โ— The rising prevalence of immunodeficiency diseases is a primary driver of the immunoglobulin market.
โ— The increasing Awareness and diagnosis of immunodeficiency diseases is reshaping the immunoglobulin market.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/immunoglobulin-market/requestsample

๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

โ— ๐‘๐ข๐ฌ๐ข๐ง๐  ๐ฉ๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ฒ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ:

As the number of individuals diagnosed with primary immunodeficiency diseases and secondary immunodeficiencies is growing, there is a higher demand for immunoglobulin therapies to manage and treat these conditions. Immunoglobulin therapies are critical for patients with immunodeficiencies, as they provide necessary antibodies to help the body fight infections. This creates a consistent demand for immunoglobulin products. Enhanced awareness and advancements in diagnostic techniques have led to earlier detection of immunodeficiency diseases. This results in timely treatment with immunoglobulin therapies, increasing overall market demand. Many patients with immunodeficiency require lifelong immunoglobulin therapy, leading to sustained usage and a stable market demand. This chronic treatment aspect fosters ongoing revenue for manufacturers.

โ— ๐€๐ ๐ข๐ง๐  ๐๐จ๐ฉ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง:

Older adults often have weakened immune systems, making them more susceptible to infections and chronic diseases. This demographic requires more immunoglobulin therapies to help bolster their immune response. As people age, they are more likely to develop chronic conditions, such as diabetes, heart disease, and autoimmune disorders. Immunoglobulin therapies are increasingly used to manage complications associated with these conditions, leading to greater demand. Diseases that commonly affect older populations, like Alzheimer's disease, Parkinson's disease, and various forms of cancer, can benefit from immunoglobulin treatment, creating a need for these therapies. The elderly often require long-term care and management of multiple health issues, leading to a consistent need for immunoglobulin therapies. This ongoing treatment need fosters a stable market for immunoglobulin products.

โ— ๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ข๐ง๐  ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐š๐ง๐ ๐๐ข๐š๐ ๐ง๐จ๐ฌ๐ข๐ฌ:

Improved awareness among healthcare providers and the public about immunodeficiency diseases has led to earlier diagnosis. Early intervention with immunoglobulin therapies is crucial for effective management, resulting in higher demand. As patients become more informed about their health conditions, they are more likely to seek medical attention. This proactive approach leads to more diagnoses of immunodeficiency disorders, increasing the patient population in need of immunoglobulin treatment. Ongoing education and training programs for healthcare professionals about immunodeficiency diseases and their treatment options have improved diagnostic rates and treatment outcomes. This professional awareness promotes the prescription of immunoglobulin therapies. The development of advanced diagnostic technologies has facilitated the accurate identification of immunodeficiencies. Improved testing methods increase the likelihood of diagnosis, leading to more patients receiving necessary immunoglobulin treatments.

๐๐ฎ๐ฒ ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/checkout?id=4505&method=502

๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ:

โ— IgG
โ— IgA
โ— IgM
โ— IgE
โ— IgD

IgG represents the largest segment as IgG is the most abundant immunoglobulin in human serum and is widely used for various therapeutic applications.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง:

โ— Hypogammaglobulinemia
โ— Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
โ— Immunodeficiency Disease
โ— Myasthenia Gravis
โ— Others

Immunodeficiency disease accounts for the majority of the market share. Immunodeficiency diseases require ongoing treatment with immunoglobulin therapies, resulting in a substantial demand that accounts for a significant portion of market share.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐Œ๐จ๐๐ž ๐จ๐Ÿ ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ:

โ— Intravenous Mode of Delivery
โ— Subcutaneous Mode of Delivery

Intravenous mode of delivery exhibits a clear dominance in the market due to its rapid administration and higher plasma levels of immunoglobulin, making it the preferred method for many clinicians and patients.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง:

โ— North America (United States, Canada)
โ— Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
โ— Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
โ— Latin America (Brazil, Mexico, Others)
โ— Middle East and Africa

North America enjoys the leading position in the immunoglobulin market on account of its well-established healthcare infrastructure, higher prevalence of immunodeficiency diseases, and greater access to advanced treatment options.

๐“๐จ๐ฉ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‹๐ž๐š๐๐ž๐ซ๐ฌ:

The immunoglobulin market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

โ— ADMA Biologics Inc.
โ— Baxter international Inc.
โ— Biotest AG
โ— CSL Limited
โ— Grifols S.A
โ— Kedrion S.p.A
โ— LFB SA
โ— Octapharma AG
โ— Sanquin Plasma Products B.V.
โ— Takeda Pharmaceutical Company Limited

๐Ž๐ญ๐ก๐ž๐ซ ๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐ˆ๐Œ๐€๐‘๐‚ ๐†๐ซ๐จ๐ฎ๐ฉ

๐€๐ข๐ซ ๐ƒ๐ž๐Ÿ๐ž๐ง๐ฌ๐ž ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:ย https://www.imarcgroup.com/air-defense-systems-market

๐‚๐จ๐ฆ๐›๐ข๐ง๐ž ๐‡๐š๐ซ๐ฏ๐ž๐ฌ๐ญ๐ž๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:ย https://www.imarcgroup.com/combine-harvesters-market

๐‚๐จ๐ฆ๐ฆ๐ž๐ซ๐œ๐ข๐š๐ฅ ๐‘๐ž๐Ÿ๐ซ๐ข๐ ๐ž๐ซ๐š๐ญ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ:ย https://www.imarcgroup.com/commercial-refrigeration-market

๐–๐จ๐จ๐ ๐๐ฎ๐ฅ๐ฉ ๐Œ๐š๐ซ๐ค๐ž๐ญ:ย https://www.imarcgroup.com/wood-pulp-market

๐‘๐ž๐ญ๐š๐ข๐ฅ ๐‘๐ž๐š๐๐ฒ ๐๐š๐œ๐ค๐š๐ ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ:ย https://www.imarcgroup.com/retail-ready-packaging-market

๐๐จ๐ญ๐ž: ๐ˆ๐Ÿ ๐ฒ๐จ๐ฎ ๐ซ๐ž๐ช๐ฎ๐ข๐ซ๐ž ๐š๐ง๐ฒ ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐ญ๐ก๐š๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐œ๐จ๐ฏ๐ž๐ซ๐ž๐ ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฐ๐ข๐ญ๐ก๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐œ๐จ๐ฉ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ฐ๐ž ๐ฐ๐ข๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ž ๐š๐ฌ ๐š ๐ฉ๐š๐ซ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoglobulin Market Set to Surge to USD 24.9 Billion by 2032 at a 5.1% CAGR here

News-ID: 3692639 • Views: โ€ฆ

More Releases from IMARC Group

Mexico Nutritional Supplements Market Size, Growth, Latest Trends and Forecast 2025-2033
Mexico Nutritional Supplements Market Size, Growth, Latest Trends and Forecast 2 โ€ฆ
IMARC Group has recently released a new research study titled "Mexico Nutritional Supplements Market Size, Share, Trends and Forecast by Product Type, Form, Distribution Channel, Consumer Group, and Region, 2025-2033" which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios. Market Overview The Mexico nutritional supplements market size was valued at USD 5.78 Billion in 2024. It isโ€ฆ
US Cold Storage Market Size, Trends, Growth and Forecast 2026-2034
US Cold Storage Market Size, Trends, Growth and Forecast 2026-2034
IMARC Group has recently released a new research study titled "US Cold Storage Market Size, Share, Trends and Forecast by Warehouse Type, Construction Type, Temperature Type, Application, and Region, 2026-2034", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. Market Overview The US cold storage market size reached USD 46,283.55 Million in 2025 and is projected to growโ€ฆ
United States Carbon Black Market Size, Trends, Growth and Forecast 2025-2033
United States Carbon Black Market Size, Trends, Growth and Forecast 2025-2033
IMARC Group has recently released a new research study titled "United States Carbon Black Market Size, Share, Trends and Forecast by Type, Grade, Application, and Region, 2025-2033" which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios. Market Overview The United States carbon black market size was valued at USD 2.51 Billion in 2024 and is projected toโ€ฆ
Silica Sand Market is Projected to Reach USD 38.3 Billion by 2034 | At CAGR 4.7%
Silica Sand Market is Projected to Reach USD 38.3 Billion by 2034 | At CAGR 4.7%
Silica Sand Market Overview: The global Silica Sand Market was valued at USD 25.4 Billion in 2025 and is forecast to reach USD 38.3 Billion by 2034, growing at a CAGR of 4.7% during 2026-2034. This growth is driven by increasing demand from the construction and glass manufacturing industries, continual advancements in hydraulic fracturing technology in oil and gas extraction, and rapid changes in environmental and regulatory landscapes. The silica sand marketโ€ฆ

All 5 Releases


More Releases for Immunoglobulin

Immunoglobulin Market Forecast 2035 | Advancing Therapeutic Outcomes: Growth of โ€ฆ
An extensive study of propelling opportunities in, "Immunoglobulin Market Size, Share & Trends Analysis Report by Product Type (IgG, IgA, IgM, IgE, IgD), Form, Route of Administration, Application, Source, Technology, Therapy Type, Patient Demographics, End-user / Distribution Channel and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A comprehensive report of growing market landscapes in the immunoglobulin sectorโ€ฆ
Rabies Immunoglobulin Market - Dynamics and Growth Pattern
The "Rabies Immunoglobulin Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Rabies Immunoglobulin Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leadingโ€ฆ
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements โ€ฆ
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate? There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,โ€ฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โ€ฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, Southโ€ฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โ€ฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,โ€ฆ
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) ofโ€ฆ